Insights into the evolution of Candidalysin and recent developments
- PMID: 40742540
- DOI: 10.1007/s00203-025-04414-z
Insights into the evolution of Candidalysin and recent developments
Abstract
The alarming rise in fungal infections poses a serious health concern worldwide. Candida albicans is a highly virulent, ubiquitous opportunistic fungal pathogen associated with high mortality, particularly in immunocompromised individuals. Its infections range from superficial mucosal to invasive candidiasis. The pathogenicity of C. albicans is largely attributed to its ability to undergo phenotypic switching between different morphological forms ranging from unicellular to hyphae. A key factor in its pathogenesis is candidalysin, a fungal cytolytic peptide toxin. Candidalysin is generated through the expression of the ECE1 polyprotein, which, upon cleavage by the protease Kex2, yields both candidalysin and non-candidalysin ECE1-derived peptides. Notably, despite its critical role in virulence, the ECE1 gene is not widely conserved among fungal pathogens and is predominantly restricted to a few Candida species. This review highlights recent advances in understanding candidalysin-mediated cell damage and immune activation pathways, and also provides insights into the evolution of the ECE1 gene and its potential role in the coevolution of C. albicans with its human host.
Keywords: Candida albicans; ECE1; Candidalysin; Evolution; Pathogenesis; Virulence.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
References
-
- Achkar JM, Fries BC (2010) Candida infections of the genitourinary tract. Clin Microbiol Rev 23(2):253–273. https://doi.org/10.1128/CMR.00076-09 - DOI - PubMed - PMC
-
- Aggor FEY, Break TJ, Trevejo-Nuñez G, Whibley N, Coleman BM, Bailey RD, Kaplan DH, Naglik JR, Shan W, Shetty AC, McCracken C, Durum SK, Biswas PS, Bruno VM, Kolls JK, Lionakis MS, Gaffen SL (2020) Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis. Sci Immunol 5(48):eaba0570. https://doi.org/10.1126/sciimmunol.aba0570 - DOI - PubMed - PMC
-
- Bader O, Krauke Y, Hube B (2008) Processing of predicted substrates of fungal Kex2 proteinases from Candida albicans, C. glabrata, Saccharomyces cerevisiae and Pichia pastoris. BMC Microbiol 8:116. https://doi.org/10.1186/1471-2180-8-116 - DOI - PubMed - PMC
-
- Bailey DA, Feldmann PJ, Bovey M, Gow NA, Brown AJ (1996) The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J Bacteriol 178(18):5353–5360. https://doi.org/10.1128/jb.178.18.5353-5360.1996 - DOI - PubMed - PMC
-
- Bailey TL, Johnson J, Grant CE, Noble WS (2015) The MEME suite. Nucleic Acids Res 43(W1):W39–W49. https://doi.org/10.1093/nar/gkv416 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources